Published Erratum
doi: 10.3389/fimmu.2022.952446.
eCollection 2022.
Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
Affiliations
- PMID: 35747141
- PMCID: PMC9210665
- DOI: 10.3389/fimmu.2022.952446
Item in Clipboard
Published Erratum
Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
Front Immunol.
.
Abstract
[This corrects the article DOI: 10.3389/fimmu.2022.913464.].
Keywords: hepatic arterial infusion chemotherapy; hepatocellular carcinoma; immune checkpoint inhibitors; systematic review; transarterial chemoembolization; tyrosine kinase inhibitors.
Copyright © 2022 Ke, Xin, Fang, Zeng, Wang and Liu.
Erratum for
-
The Significance of Transarterial Chemo(Embolization) Combined With Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.Front Immunol. 2022 May 23;13:913464. doi: 10.3389/fimmu.2022.913464. eCollection 2022. Front Immunol. 2022. PMID: 35677059 Free PMC article.
Similar articles
-
The Significance of Transarterial Chemo(Embolization) Combined With Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.Front Immunol. 2022 May 23;13:913464. doi: 10.3389/fimmu.2022.913464. eCollection 2022. Front Immunol. 2022. PMID: 35677059 Free PMC article.
-
A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization).Liver Cancer. 2024 May 13;13(4):335-343. doi: 10.1159/000539301. eCollection 2024 Aug. Liver Cancer. 2024. PMID: 39114759 Free PMC article. No abstract available.
-
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.AJR Am J Roentgenol. 2010 Mar;194(3):830-7. doi: 10.2214/AJR.09.3308. AJR Am J Roentgenol. 2010. PMID: 20173167
-
Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response.Front Immunol. 2022 Feb 18;13:847601. doi: 10.3389/fimmu.2022.847601. eCollection 2022. Front Immunol. 2022. PMID: 35300339 Free PMC article.
-
Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.Semin Oncol. 2010 Apr;37(2):89-93. doi: 10.1053/j.seminoncol.2010.03.007. Semin Oncol. 2010. PMID: 20494700 Review.
Cited by
-
Outcomes of Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma Converted by Transcatheter Arterial Chemoembolization Combined with Lenvatinib plus Anti-PD-1 Antibodies: A Multicenter Retrospective Study.Liver Cancer. 2022 Nov 30;12(3):229-237. doi: 10.1159/000528356. eCollection 2023 Aug. Liver Cancer. 2022. PMID: 37767067 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
